Parkinson's disease (PD), the second most common neurodegenerative disease worldwide,
often occurs in middle-aged and elderly individuals. The pathogenesis of PD is complex and …

Parkinson's disease (PD) is one of the most prevalent and debilitating neurodegenerative
conditions, and is currently on the rise. Several dysregulated pathways are behind the …

Parkinson's disease (PD) is a well-known age-related neurodegenerative disorder
associated with longer lifespans and rapidly aging populations. The pathophysiological …

Mitochondria are considered the only source of energy production within cells. This
organelle is vital for neural function and survival by producing energy (adenosine …

Mitochondrial damage is associated with the development of Parkinson's disease (PD),
indicating that mitochondrial‐targeted treatments could hold promise as disease‐modifying …

Abstracts Alzheimer's disease (AD) is the most common progressive neurodegenerative
disorder characterized by neuronal loss and cognitive impairment that harshly affect the …

As the global population ages, the prevalence of Parkinson's disease (PD) is steadily on the
rise. PD demonstrates chronic and progressive characteristics, and many cases can …

Mitochondria are the primary source of energy production in cells, supporting the metabolic
demand of tissue. The dysfunctional mitochondria are implicated in various diseases …

Parkinson's disease (PD) is the most common progressive neurodegenerative movement
disorder affecting more than 10 million people worldwide. The characteristic hallmark of PD …

Current pharmacological strategies for Parkinson's disease (PD), the most common
neurological movement disorder worldwide, are predominantly symptom relieving and are …